Status of the BRCA1 gene and incidence of hereditary ovarian cancer

Agnieszka Synowiec; Gabriel Wcisło; Lubomir Bodnar; Katarzyna Szarlej-Wcisło; Agata Cieślak; Joanna Sielużycka; Cezary Szczylik

doi:10.5114/wo.2010.13915

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2010
vol. 14

Send email

Copy url:

abstract:

Review paper

Status of the BRCA1 gene and incidence of hereditary ovarian cancer

Agnieszka Synowiec

,

Gabriel Wcisło

,

Lubomir Bodnar

,

Katarzyna Szarlej-Wcisło

,

Agata Cieślak

,

Joanna Sielużycka

,

Cezary Szczylik

Współczesna Onkologia (2010) vol. 14; 2 (72–78)

DOI: https://doi.org/10.5114/wo.2010.13915

Online publish date: 2010/04/30

View full text Get citation

PlumX metrics:

Ovarian cancer is the leading cause of mortality in women with gynaecological cancers. Cytoreductive surgery has been considered as a mainstay in management of ovarian cancer for a long time. Further chemotherapy, based on platinum compounds and taxanes given in an adjuvant setting, allows 5-year survival to be achieved in 10-30% of ovarian cancer patients. Among these cases, it is thought that 5-10% of patients have familial or hereditary disease in which mutations within BRCA genes are the main culprits of 80-90% of ovarian cancer sufferers. The risk of ovarian cancer development in carriers of a mutated BRCA1 gene is 16-60%, which underlines the great need for a precise tool in the form of molecular tests. Now it is time for development of a direct-to-consumer (DTC) strategy that offers commercially available molecular tests with wide utility.

keywords:

Status of the BRCA1 gene and incidence of hereditary ovarian cancer

Agnieszka Synowiec , Gabriel Wcisło , Lubomir Bodnar , Katarzyna Szarlej-Wcisło , Agata Cieślak , Joanna Sielużycka , Cezary Szczylik

ovarian cancer, BRCA1, founder effect mutations, genetic tests

Agnieszka Synowiec

,

Gabriel Wcisło

,

Lubomir Bodnar

,

Katarzyna Szarlej-Wcisło

,

Agata Cieślak

,

Joanna Sielużycka

,

Cezary Szczylik